In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
This episode introduces new podcast cohosts Amy LaLonde and Christina Nurse! They take over hosting duties starting with Episode 101.
James Buchanan, Judy Li, Melvin Munsaka, and Bill Wang discuss the research of the Safety Scientific Working Group and their recent edited volume "Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches." https://tinyurl.com/2ucyer95
Devan discusses the 5-STAR methodology and endpoints for COVID vaccine clinical trials.
Alan is the 2022 Chair of the Biopharmaceutical Section. He discusses his wish list for things to accomplish this year.
Anna Nevius reflects on her time at the Center for Veterinary Medicine at the FDA and as chair of the Biopharmaceutical Section in 2009.
Bob Starbuck reflects on his time as chair of the Biopharmaceutical Section in 1994.
Amy Xia and Lanju Zhang discuss the benefits and challenges of utilizing external control arms for clinical trials.
Bo Huang and Gene Pennello discuss the 2021 Regulatory-Industry Statistics Workshop.
Joseph Cappelleri and Daniel O’Connor discuss the benefits and challenges in using patient reported outcomes and how to appropriately define clinically-meaningful change.
Haoda Fu, Mengling Liu, Jie Tang, Tian Zheng, and Kelly Zou discuss leadership and the impact of COVID-19 on the workplace.
Karl Peace was chair of the Biopharmaceutical Section in 1990. He discusses his career in the industry, the Jiann-Ping Hsu College of Public Health, and the Biopharmaceutical Applied Statistics Symposium.
Katherine Monti was chair of the Biopharmaceutical Section in 2010. She discusses her career in the industry and how the Section has changed over time.
Scott Evans, Stephanie Omokaro, Janet Wittes, and Zhiheng Xu discuss the importance of storytelling for the modern statistician.
Meg Gamalo and Jingjing Ye talk about pediatric drug development and discuss why forming a scientific working group was so important.
Weili talks about publishing, leadership, and her hopes and plans for the Biopharmaceutical Section in 2021.
David shares some of his experiences as the first statistician ever hired at Pfizer.
Kerry Go and Elaine Hoffman discuss vaccine development.
Olga and Natallia discuss their new book Quantitative Methods in Pharmaceutical Research and Development: Concepts and Applications.
This episode features discussions with 3 mentor-mentee pairs from the Biopharmaceutical Section mentoring program. Conversations include Qing Li and Abie Ekangaki (start 1:25), Samson Ghebremariam and Scott Clark (start 44:33), and Carie Kimbrough and Bruce Binkowitz (start 102:29). They discuss the benefits of mentoring and the dynamics of the mentoring relationship.
Yabing Mai and Thomas Birkner discuss the 2020 Workshop and the changes necessary to go virtual.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
If you can never get enough true crime... Congratulations, you’ve found your people.
It’s a lighthearted nightmare in here, weirdos! Morbid is a true crime, creepy history and all things spooky podcast hosted by an autopsy technician and a hairstylist. Join us for a heavy dose of research with a dash of comedy thrown in for flavor.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks then look no further. Josh and Chuck have you covered.
Hosted by Laura Beil (Dr. Death, Bad Batch), Sympathy Pains is a six-part series from Neon Hum Media and iHeartRadio. For 20 years, Sarah Delashmit told people around her that she had cancer, muscular dystrophy, and other illnesses. She used a wheelchair and posted selfies from a hospital bed. She told friends and coworkers she was trapped in abusive relationships, or that she was the mother of children who had died. It was all a con. Sympathy was both her great need and her powerful weapon. But unlike most scams, she didn’t want people’s money. She was after something far more valuable.